Sidoti Csr Reduces Earnings Estimates for SBC Medical Group

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Stock analysts at Sidoti Csr dropped their FY2024 earnings per share (EPS) estimates for SBC Medical Group in a note issued to investors on Wednesday, March 26th. Sidoti Csr analyst A. Shah now forecasts that the company will post earnings of $0.57 per share for the year, down from their prior forecast of $0.58. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group’s Q1 2025 earnings at $0.16 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.64 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.18 EPS, Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.19 EPS and FY2026 earnings at $0.71 EPS.

SBC Medical Group Trading Down 12.5 %

Shares of SBC Medical Group stock opened at $3.28 on Thursday. The business’s 50-day moving average price is $4.41. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.76 and a current ratio of 2.79. SBC Medical Group has a 12-month low of $2.62 and a 12-month high of $12.50.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.